Skip to main content
Clinical Trials/CTRI/2023/10/058621
CTRI/2023/10/058621
Not Yet Recruiting
Phase 2

Accelerated Hypofractionated Palliative Radiotherapy Vs Standard Hypofractionated Palliative Radiotherapy With Concurrent Chemotherapy In Locally Advanced Head And Neck Carcinoma: A Randomised Controlled Study - nil

AIIMS, New Delhi0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
AIIMS, New Delhi
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
AIIMS, New Delhi

Eligibility Criteria

Inclusion Criteria

  • Treatment naive, Histo\-pathologically proven Squamous Cell Carcinoma of head and neck region excluding nasopharyngeal, para\-nasal sinus and salivary gland primary
  • \-Defined as incurable or palliative intent by Head and Neck multidisciplinary team (MDT)
  • \-Adequate organ functions and bone marrow reserve
  • \-Eastern Co\-operative Oncology Group Performance Score (ECOG PS)\- (0\-3\)
  • \-Age: 18\- 70 years
  • \-Negative viral serology markers (HIV, HBsAg, HCV)
  • \-Giving written Informed consent

Exclusion Criteria

  • \-Nasopharyngeal, para\-nasal sinus or salivary gland primary
  • \-Recurrent disease
  • \-Metastatic disease
  • \-Patients who have previously received oncologic treatment with surgery, radiotherapy or chemotherapy
  • \-Pregnant patients
  • \-Synchronous malignancy or any other malignancy with in last 5 years
  • \-Known uncontrolled medical comorbidities which could impact QOL

Outcomes

Primary Outcomes

Not specified

Similar Trials